AGMO Inhibitor Reduces 3T3-L1 Adipogenesis
Alkylglycerol monooxygenase (AGMO) is a tetrahydrobiopterin (BH4)-dependent enzyme with major expression in the liver and white adipose tissue that cleaves alkyl ether glycerolipids. The present study describes the disclosure and biological characterization of a candidate compound (Cp6), which inhib...
Main Authors: | Caroline Fischer, Annett Wilken-Schmitz, Victor Hernandez-Olmos, Ewgenij Proschak, Holger Stark, Ingrid Fleming, Andreas Weigert, Manuela Thurn, Martine Hofmann, Ernst R. Werner, Gerd Geisslinger, Ellen Niederberger, Katrin Watschinger, Irmgard Tegeder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/5/1081 |
Similar Items
-
The Emerging Physiological Role of AGMO 10 Years after Its Gene Identification
by: Sabrina Sailer, et al.
Published: (2021-01-01) -
Adaptations of the 3T3-L1 adipocyte lipidome to defective ether lipid catabolism upon Agmo knockdown
by: Sabrina Sailer, et al.
Published: (2022-06-01) -
Expression of full-length human alkylglycerol monooxygenase and fragments in Escherichia coli
by: Mayer Matthias, et al.
Published: (2013-06-01) -
Xylitol does not directly affect adiponectin productionand adipogenesis in 3T3-L1 cells
by: Pilaiwan Siripurkpong, et al.
Published: (2014-08-01) -
Caveolae-Associated Protein 3 (Cavin-3) Influences Adipogenesis via TACE-Mediated Pref-1 Shedding
by: Phil June Park, et al.
Published: (2020-07-01)